SAFETY, EFFECTIVENESS AND CLINICAL OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS DELTA TREATED WITH BULEVIRTIDE MONOTHERAPY: A POOLED ANALYSIS ON 689 PATIENTS ENROLLED IN THE SAVE-D AND D-SHIELD STUDIES

Conference Reports for NATAP

The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025


SAFETY, EFFECTIVENESS AND CLINICAL OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS DELTA TREATED WITH BULEVIRTIDE MONOTHERAPY: A POOLED ANALYSIS ON 689 PATIENTS ENROLLED IN THE SAVE-D AND D-SHIELD STUDIES

	AASLD 2025 Nov 7-11 Wash DC Elisabetta Degasperi1